Related Experiment Video
Updated: Nov 10, 2025

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
Published on: May 5, 2022
Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and
Øyvind H Lie1,2, Monica Chivulescu1,2, Christine Rootwelt-Norberg1,2
1Department of Cardiology Oslo University Hospital, Rikshospitalet Norway.
Insights
Greater exercise is linked to worse left ventricular (LV) function in arrhythmogenic cardiomyopathy (AC) patients at diagnosis. LV function decline predicts arrhythmias, especially in desmoplakin genotype carriers.
Area of Science:
- Cardiology
- Genetics
- Cardiovascular Imaging
Background:
- Arrhythmogenic cardiomyopathy (AC) presents with biventricular dysfunction, exercise intolerance, and high risk of ventricular tachyarrhythmias and sudden death.
- Factors influencing left ventricular (LV) disease manifestation and prognosis in AC remain incompletely understood.
- Left ventricular dysfunction is a critical determinant of adverse outcomes in AC.
Purpose of the Study:
- To investigate the association between exercise exposure and genotype with LV dysfunction in AC.
- To determine the impact of LV disease progression on the risk of adverse arrhythmic events.
- To identify predictors of LV dysfunction progression and subsequent ventricular tachyarrhythmias in AC.
Main Methods:
- Longitudinal study of 168 AC patients with comprehensive echocardiographic follow-up (7.6 years).
- Assessment of LV function using global longitudinal strain (GLS) and correlation with exercise data.
- Analysis of genetic data, focusing on desmoplakin genotype, and its interaction with LV function progression.
Main Results:
- Higher exercise exposure correlated with worse baseline LV function (GLS worsening per 5 MET-hours/week, P=0.02).
- LV function significantly worsened over time (0.08% per year, P<0.001), with accelerated progression in desmoplakin genotype patients (P<0.001).
- Deterioration in LV function predicted incident ventricular tachyarrhythmias (OR 1.1 per 1% GLS worsening, P=0.02).
Conclusions:
- Exercise exposure is associated with baseline LV dysfunction but not the rate of LV progression in AC.
- LV dysfunction progression is most pronounced in patients with desmoplakin genotypes.
- Monitoring LV function deterioration is crucial for risk stratification of ventricular tachyarrhythmias in AC.
Abstract:
Background Arrhythmogenic cardiomyopathy (AC) is characterized by biventricular dysfunction, exercise intolerance, and high risk of ventricular tachyarrhythmias and sudden death. Predisposing factors for left ventricular (LV) disease manifestation and its prognostic implication in AC are poorly described. We aimed to assess the associations of exercise exposure and genotype with LV dysfunction in AC, and to explore the impact of LV disease progression on adverse arrhythmic outcome. Methods and Results We included 168 patients with AC (50% probands, 45% women, 40±16 years old) with 715 echocardiographic exams (4.1±1.7 exams/patient, follow-up 7.6 [interquartile range (IQR), 5.4-10.9] years) and complete exercise and genetic data in a longitudinal study. LV function by global longitudinal strain was -18.8% [IQR, -19.2% to -18.3%] at presentation and was worse in patients with greater exercise exposure (global longitudinal strain worsening, 0.09% [IQR, 0.01%-0.17%] per 5 MET-hours/week, P=0.02). LV function by global longitudinal strain worsened, with 0.08% [IQR, 0.05%-0.12%] per year; (P<0.001), and progression was most evident in patients with desmoplakin genotype (P for interaction <0.001). Deterioration of LV function predicted incident ventricular tachyarrhythmia (aborted cardiac arrest, sustained ventricular tachycardia, or implantable cardioverter defibrillator shock) (adjusted odds ratio, 1.1 [IQR, 1.0-1.3] per 1% worsening by global longitudinal strain; P=0.02, adjusted for time and previous arrhythmic events). Conclusions Greater exercise exposure was associated with worse LV function at first visit of patients with AC but did not significantly affect the rate of LV progression during follow-up. Progression of LV dysfunction was most pronounced in patients with desmoplakin genotypes. Deterioration of LV function during follow-up predicted subsequent ventricular tachyarrhythmia and should be considered in risk stratification.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
14:39Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology